Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis
Courtney Perry, Kyle B. Fischer, Ahmed Elmoursi, Cody Kern, Alden Currier, Praneeth Kudaravalli, Olalekan Akanbi, Nishant Tripathi, Pradeep Yarra, Leon Su, Deborah Flomenhoft, Arnold J. Stromberg, Terrence A. Barrett
Topics & Concepts
DosingMedicineVedolizumabUlcerative colitisInternal medicineHepatologyClinical trialGastroenterologyDiseaseInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods